2021. RFLSP.Russian.Finnish.Life.Science.Industry.EN

More documents

Recommendations

Info

144RUSSIAN-FINNISH LIFE SCIENCE INDUSTRYResearch and export directory
Page 2 and 3:
This publication was developed in t
Page 4 and 5:
1.5 Events ........................
Page 6 and 7:
2.42 PHARM-HOLDING ................
Page 8 and 9:
1 PART 1: MARKET RESEARCH1.1 Indust
Page 10 and 11:
The Russian pharmaceutical market i
Page 12 and 13:
Imported/localized drugs sales rati
Page 14 and 15:
In 2020, the share of original drug
Page 16 and 17:
1.1.2 Commercial segment of the Rus
Page 18 and 19:
1.1.3 Drug reimbursement segmentAcc
Page 20 and 21:
1.1.4 Segment of purchases of drugs
Page 22 and 23:
1.1.5 Dietary supplements segmentAc
Page 24 and 25:
The development of the innovative d
Page 26 and 27:
Dynamics of pharmaceutical products
Page 28 and 29:
§ the term of the SPIC has been ex
Page 30 and 31:
The Pharma-2030 Strategy elaboratio
Page 32 and 33:
presence of viral RNA and antibodie
Page 34 and 35:
§ training system in the field of
Page 36 and 37:
counter external risks (for example
Page 38 and 39:
1.3.2 The Pavlov First Saint Peters
Page 40 and 41:
1.3.3 North-Western State Medical U
Page 42 and 43:
1.3.4 Military Medical Academy name
Page 44 and 45:
1.3.6 Saint-Petersburg State Instit
Page 46 and 47:
1.3.7 Peter the Great St. Petersbur
Page 48 and 49:
1.3.9 Saint-Petersburg Medico-Socia
Page 50 and 51:
1.4.2 Almazov National Medical Rese
Page 52 and 53:
1.4.4 Institute of Cytology RASInst
Page 54 and 55:
1.4.6 Kashkin Research Institute of
Page 56 and 57:
1.4.8 Research Institute of Hygiene
Page 58 and 59:
1.4.10 Saint-Petersburg Pasteur Ins
Page 60 and 61:
Contact informationBekhtereva Str.,
Page 62 and 63:
The Institute has Influenza and ARD
Page 64 and 65:
1.4.14 V. M. Gorbatov Federal Resea
Page 66 and 67:
1.5 Events1.5.1 Events calendarDate
Page 68 and 69:
1.5.2.2 Nordic Life Science DaysNor
Page 70 and 71:
1.5.2.4 HealthBIOThe HealthBIO even
Page 72 and 73:
1.5.2.6 BioJapanBioJapan has played
Page 74 and 75:
1.5.2.8 CPhI WorldwideCPhI is an es
Page 76 and 77:
1.5.2.10 INTERPHEX Japan 2021INTERP
Page 78 and 79:
1.5.3.2 IPhEB RussiaIPhEB Russia is
Page 80 and 81:
1.6 Clusters and associations1.6.1
Page 82 and 83:
1.6.3 Cluster of medical, environme
Page 84 and 85:
1.7 Cases and success stories1.7.1
Page 86 and 87:
1.8 Information sources1.8.1 Strate
Page 88 and 89:
§ DSM Group. Analytical report “
Page 90 and 91:
2.2 ALKOR BIOCompany profileThe St.
Page 92 and 93:
2.4 AMBERCompany profileAmber Group
Page 94 and 95: 2.6 AVENACompany profileAvena compa
Page 96 and 97: 2.8 BELKOZINCompany profileBelkozin
Page 98 and 99: 2.10 BIOCADCompany profileBiocad is
Page 100 and 101: 2.12 BIOPHARMOSCompany profileBioPh
Page 102 and 103: 2.14 BIOTECHCompany profileBiotech
Page 104 and 105: 2.16 CYTOMEDCompany profileCytomed
Page 106 and 107: 2.18 EKVUSCompany profile“Ekvus
Page 108 and 109: 2.20 FARMAKOGENCompany profileFarma
Page 110 and 111: 2.22 FRAMEBIOTEKCompany profileFram
Page 112 and 113: 2.24 GEROPHARMCompany profileGeroph
Page 114 and 115: 2.26 GROTEXCompany profileSolopharm
Page 116 and 117: 2.28 HARMSCompany profileHistory of
Page 118 and 119: 2.30 LEKKERCompany profileThe histo
Page 120 and 121: 2.32 NEPHRONCompany profileResearch
Page 122 and 123: 2.34 NIKACompany profileNika Factor
Page 124 and 125: 2.36 PHARM. ASSOCIATION NAMED FOR P
Page 126 and 127: 2.38 PHARMA VAMCompany profilePharm
Page 128 and 129: 2.40 PHARMAKOR PRODUCTIONCompany pr
Page 130 and 131: 2.42 PHARM-HOLDINGCompany profilePh
Page 132 and 133: 2.44 PHARMSYNTHEZCompany profilePha
Page 134 and 135: 2.46 PPDPCompany profileEnterprise
Page 136 and 137: 2.48 RESEARCH INSTITUTE OF INNOVATI
Page 138 and 139: 2.50 SEVERNAIA ZVEZDACompany profil
Page 140 and 141: 2.52 VITAL DEVELOPMENT CORPORATIONC
Page 142 and 143: For notes142RUSSIAN-FINNISH LIFE SC
show all

2021. RFLSP.Russian.Finnish.Life.Science.Industry.EN

Create successful ePaper yourself

Delete template?

Save as template?